Valuation: Photocure ASA

Market Cap 1.25B 136M 122M 112M 102M 190M 12.93B 194M 1.34B 537M 6.8B 511M 500M 21.45B P/E 2026 *
16.6x
P/E 2027 * 55.7x
Enterprise Value 1.09B 118M 106M 97.18M 88.05M 165M 11.2B 168M 1.16B 465M 5.89B 443M 433M 18.58B EV / Sales 2026 *
1.65x
EV / Sales 2027 * 1.66x
Free-Float
95.71%
Yield 2026 *
-
Yield 2027 * -
1 day-0.11%
1 week-6.45%
Current month-0.11%
1 month-5.31%
3 months-10.25%
6 months-31.66%
Current year-35.01%
1 week 45.55
Extreme 45.55
50.7
1 month 45.55
Extreme 45.55
50.8
Current year 45.55
Extreme 45.55
79.8
1 year 45.55
Extreme 45.55
79.8
3 years 45.55
Extreme 45.55
79.8
5 years 40.7
Extreme 40.7
127.3
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 01/11/2018
Chief Tech/Sci/R&D Officer - 01/08/2021
Human Resources Officer - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/01/2022
Chairman - 27/09/2023
Director/Board Member - 23/05/2024
Date Insider Type Main position Quantity % Market Cap. Importance
2/4/25 BuyCompany 11,355 0.0419%
2/4/25 BuyCompany 8,997 0.0332%
31/3/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.11%-6.45%-19.44%-18.31% 136M
+3.19%+11.31%+64.28%+155.66% 1,263B
-0.73%+3.56%+44.65%+83.74% 658B
+1.41%+3.24%+35.25%+106.98% 521B
-1.33%+0.30%+53.26%+67.00% 391B
+2.18%+2.93%+73.90%+45.38% 369B
-1.31%+3.59%+32.72%+55.99% 307B
-0.49%+8.12%+12.41%+34.12% 290B
+1.15%+6.09%+56.15%+78.66% 252B
+3.06%+9.38%+42.48%+112.84% 212B
Average +0.29%+4.79%+39.57%+72.21% 426.21B
Weighted average by Cap. +0.32%+6.60%+50.16%+98.80%

Financials

2026 *2027 *
Net sales 657M 71.39M 63.94M 58.81M 53.29M 99.61M 6.78B 101M 701M 282M 3.57B 268M 262M 11.24B 664M 72.22M 64.68M 59.5M 53.91M 101M 6.86B 103M 710M 285M 3.61B 271M 265M 11.38B
Net income 47M 5.11M 4.58M 4.21M 3.81M 7.13M 485M 7.26M 50.2M 20.15M 255M 19.18M 18.77M 805M 22.33M 2.43M 2.17M 2M 1.81M 3.39M 231M 3.45M 23.85M 9.58M 121M 9.11M 8.92M 382M
Net Debt -168M -18.23M -16.32M -15.02M -13.61M -25.43M -1.73B -25.91M -179M -71.89M -910M -68.41M -66.95M -2.87B -152M -16.49M -14.77M -13.58M -12.31M -23.01M -1.57B -23.44M -162M -65.03M -824M -61.88M -60.56M -2.6B
Projected Income Statement - Annual - Photocure ASA
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
02/11/26 NOK 46.40 -0.11% 46,049
30/10/26 NOK 46.45 -0.54% 75,384
29/10/26 NOK 46.70 -1.68% 154,399
28/10/26 NOK 47.50 -5.00% 269,590
27/10/26 NOK 50.00 +0.81% 142,661
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Photocure ASA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
46.45NOK
Average target price
78.00NOK
Spread / Average Target
+67.92%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Photocure ASA